EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy

Gabriela Vera, Pablo A Rojas, Joseph B Black, Ignacio F San Francisco

Cancers · 19.08.2024 · 16 (16) · 2879

DOI: 10.3390/cancers16162879 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.08.2024. Verfasst von Gabriela Vera und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Urología, Complejo Asistencial Dr. Sotero del Rio, Santiago 8207257, Chile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite curative-intent local therapy, approximately 27% to 53% of prostate cancer (PCa) patients experience prostate-specific antigen (PSA) recurrence, known as biochemical recurrence (BCR). BCR significantly raises the risk of PCa-related morbidity and mortality, yet there is no consensus on optimal management. Prostate-specific membrane antigen-positron emission tomography (PSMA PET) has emerged as highly sensitive imaging, distinguishing local recurrences from distant metastases, crucially influencing treatment decisions. Genomic biomarkers such as Decipher, Prolaris, and Oncotype DX contribute to refining recurrence risk profiles, guiding decisions on intensifying adjuvant therapies, like radiotherapy and androgen deprivation therapy (ADT). This review assesses PSMA PET and biomarker utility in post-radical prostatectomy BCR scenarios, highlighting their impact on clinical decision-making. Despite their promising roles, the routine integration of biomarkers is limited by availability and cost, requiring further evidence. PSMA PET remains indispensable for restaging and treatment evaluation in these patients. Integrating biomarkers and PSMA PET promises to optimize personalized management strategies for BCR, though more comprehensive consensus-building studies are needed to define their standardized utility in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

biomarkersnovel imagesprostate cancer recurrence

Autor:innen und Institutionen

  • Servicio de Urología, Complejo Asistencial Dr. Sotero del Rio, Santiago 8207257, Chile.
  • Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215-5400, USA.

Zitieren

APA

Vera, G., Rojas, P. A., Black, J. B., & San Francisco, I. F. (2024). Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy. Cancers, 16(16), 2879. https://doi.org/10.3390/cancers16162879

Vancouver

Vera G, Rojas PA, Black JB, San Francisco IF. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy. Cancers. 2024;16(16):2879. doi:10.3390/cancers16162879

BibTeX
@article{Vera2024,
  author = {Vera, Gabriela and Rojas, Pablo A and Black, Joseph B and San Francisco, Ignacio F},
  title = {Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {16},
  pages = {2879},
  doi = {10.3390/cancers16162879}
}
Kostenlos starten →